GRI Bio
Cash Flow

Last updated:

Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of GRI Bio generated cash of -$9,140,000, which is less than the previous year. Cash used in financing activities reached the amount of $10,947,000 last year. Net change in cash is therefore $1,799,000.

Cash Flow

GRI Bio, Inc. (NASDAQ:GRI): Cash Flow
2019 -2.88M 0 6.09M
2020 -3.70M -2K -4K
2021 -847K -3.84M 600K
2022 -1.08M -3K 1.00M
2023 -9.14M -8K 10.94M

GRI Cash Flow Statement (2019 – 2023)

2023 2022 2021 2020 2019
Cash at beginning of period
9K90K337K3.82M612.65K
Operating activities
Net income
-13.03M-3.21M-1.55M-4.82M-3.46M
Adjustments to reconcile net income to cash generated by operating activities:
Depreciation and amortization
57K50K49K75K735
Stock-based compensation expense
025K000
Deferred income tax benefit 025K000
Changes in operating assets and liabilities:
Accounts receivable, net
00000
Inventories
00000
Accounts payable
2.15M897K54K980K-40.28K
Cash generated by operating activities
-9.14M-1.08M-847K-3.70M-2.88M
Investing activities
Purchases Of Investments
-699K-640K-3.84M00
Investments In Property Plant And Equipment
-8K-3K0-2K0
Acquisitions Net
00000
Cash generated by investing activities
-8K-3K-3.84M-2K0
Financing activities
Common Stock Issued
12.25M0100K04.98M
Payments for dividends
00000
Repurchases of common stock
0-124K000
Repayments of term debt
1.25M1.23M-244K-4K1.11M
Cash used in financing activities
10.94M1.00M600K-4K6.09M
Net Change In Cash
1.79M-81K-247K-3.71M3.20M
Cash at end of period
1.80M9K90K109K3.82M